An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data

Stopped early · Phase 3

Conditions studied: Uveitis

In brief

The purpose of this study is to provide continued dosing of gevokizumab in order to obtain and assess long-term gevokizumab safety data.

Key facts

Study ID

NCT02258854

Run by

XOMA (US) LLC

People needed

69

Starts

2014-03-01

Expected to finish

2017-12-01

Last updated by the study team

2015-10-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed either the X052130/CL3-78989-005 or the X052131/CL3-78989-006 study's masked D392 or OL-224 completion day visits or had controlled ocular inflammation after having received study drug in Part 2 of study X052133

You may not qualify if…

• Discontinued from the previous study
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Study site — Chandler, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Beverly Hills, California, United States
• Study site — Redlands, California, United States
• Study site — Riverside, California, United States
• Study site — Sacramento, California, United States
• Study site — Santa Ana, California, United States
• Study site — Victorville, California, United States
• Study site — Golden, Colorado, United States
• Study site — Littleton, Colorado, United States
• Study site — Bridgeport, Connecticut, United States
• Study site — Lakeland, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Ellsworth, Maine, United States
• Study site — Baltimore, Maryland, United States
• Study site — Cambridge, Massachusetts, United States
• Study site — Waltham, Massachusetts, United States
• Study site — Jackson, Michigan, United States
• Study site — Royal Oak, Michigan, United States
• Study site — Omaha, Nebraska, United States
• Study site — Bloomfield, New Jersey, United States
• Study site — Teaneck, New Jersey, United States
• Study site — Belmont, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.